ABSI
HealthcareAbsci Corporation
$3.74
+$0.13 (+3.60%)
Jan 5, 2026
Price History (1Y)
Analysis
Absci Corporation is a biotechnology company operating in the healthcare sector. With a market capitalization of $562.39M and 156 employees, it falls within the realm of smaller-scale companies in its industry. The financial health of Absci Corporation indicates significant challenges. The company has reported zero gross margin, an operating margin of -7977.2%, and a profit margin of 0.0%. Returns on equity (ROE) and assets (ROA) have also been negative at -55.7% and -30.6%, respectively. On the balance sheet, Absci Corporation has $152.48M in cash and $6.22M in debt, resulting in a debt-to-equity ratio of 2.96. Valuation metrics for Absci Corporation reveal a complex picture. With a forward P/E ratio of -5.56, the company's stock price may be influenced by investors' expectations for future earnings growth. Revenue has decreased by 77.8% year-over-year, while the dividend yield is not applicable due to the absence of dividend payments.
This analysis is AI-generated for informational purposes only and should not be considered financial advice. Data may be delayed or inaccurate. Always do your own research and consult a qualified financial advisor before making investment decisions.
About Absci Corporation
Absci Corporation operates as a data-first generative artificial intelligence (AI) drug creation company in the United States. The company combines AI with scalable wet lab technologies to design differentiated antibody therapeutics. Its preclinical development programs include ABS-101 for the treatment of inflammatory bowel disease; ABS-201 for treating androgenic alopecia; ABS-301 for the treatment of immuno-oncology; and ABS-501 for treating oncology. Absci Corporation has collaboration agreements with PrecisionLife, Memorial Sloan Kettering Cancer Center, Twist Bioscience, Owkin, Oracle Corporation, and Advanced Micro Devices, Inc. for joint research and development activities. The company was founded in 2011 and is headquartered in Vancouver, Washington.
Visit website →Key Statistics
- Market Cap
- $562.39M
- P/E Ratio
- N/A
- 52-Week High
- $6.33
- 52-Week Low
- $2.01
- Avg Volume
- 4.78M
- Beta
- 2.13
Company Info
- Industry
- Biotechnology
- Exchange
- NMS
- Country
- United States
- Employees
- 156